Document is current

Any future updates will be listed below

Liposomal anthracycline chemotherapy and the risk of second malignancies in patients with Kaposi’s sarcoma (KS)

Crossref DOI link: https://doi.org/10.1007/s00280-014-2538-1

Published Online: 2014-07-24

Published Print: 2014-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark